25 May 2013
Keywords: gilead, cidofovir, gel, genital, warts, sciences, begun
Article | 08 April 1996
Gilead Sciences has begun a study of cidofovir topical gel as a treatment for human papillomavirus-associated genital warts in immunocompetent ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.